According to Sarepta Therapeutics
's latest financial reports the company has โน102.90 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | โน139.54 B | -15.23% |
2022-12-31 | โน164.62 B | 4.53% |
2021-12-31 | โน157.48 B | 11.08% |
2020-12-31 | โน141.77 B | 76.76% |
2019-12-31 | โน80.20 B | -2.29% |
2018-12-31 | โน82.08 B | 19.14% |
2017-12-31 | โน68.89 B | 218.99% |
2016-12-31 | โน21.59 B | 68.85% |
2015-12-31 | โน12.79 B | -4.04% |
2014-12-31 | โน13.33 B | -16.03% |
2013-12-31 | โน15.87 B | 54.5% |
2012-12-31 | โน10.27 B | 386.75% |
2011-12-31 | โน2.11 B | 40.25% |
2010-12-31 | โน1.50 B | -32.81% |
2009-12-31 | โน2.23 B | 306.16% |
2008-12-31 | โน0.55 B | -43.96% |
2007-12-31 | โน0.98 B | -32.98% |
2006-12-31 | โน1.46 B | -30.65% |
2005-12-31 | โน2.11 B | 150.52% |
2004-12-31 | โน0.84 B | -50.63% |
2003-12-31 | โน1.71 B | 85.03% |
2002-12-31 | โน0.92 B | -25.09% |
2001-12-31 | โน1.23 B | -17.59% |
2000-12-31 | โน1.49 B | 197.2% |
1999-12-31 | โน0.50 B | 39.53% |
1998-12-31 | โน0.36 B | -47.75% |
1997-12-31 | โน0.69 B | 541.34% |
1996-12-31 | โน0.10 B |